Jason Binder, Head of Patient Experience at Pathos, shared on LinkedIn:
“Precision Access or Pay-to-Play?
GBM families are chasing science-backed options abroad. But in Germany, access may mean a regulated compassionate use program or a pay-to-play named-patient route with no protections.
New post on BrainStorm Health.”
More posts featuring GBM.